Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.69
+0.72 (0.32%)
AAPL  268.41
-0.40 (-0.15%)
AMD  260.23
+0.56 (0.22%)
BAC  52.85
-0.17 (-0.31%)
GOOG  267.97
-1.96 (-0.73%)
META  752.47
+1.65 (0.22%)
MSFT  543.00
+11.48 (2.16%)
NVDA  192.72
+1.23 (0.64%)
ORCL  282.00
+0.60 (0.21%)
TSLA  461.33
+8.91 (1.97%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.